Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion type Assertion NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_head.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion wasGeneratedBy ECO_0000203 NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_provenance.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion wasDerivedFrom befree-20150227 NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_provenance.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion SIO_000772 20582464 NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_provenance.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion evidence source_evidence_literature NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_provenance.
- NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_assertion description "[In conclusion, a promising defective DNA repair gene expression signature appears to differentiate TN breast cancers that are sensitive to anthracyclines and resistant to taxane-based chemotherapy, and should be tested in clinical trials with other DNA-damaging agents and PARP-1 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880596.RAgEe8TxBnMBmSNQL67T7at43n8kw_J0roS9QgFl1N7V4130_provenance.